Friday, June 14, 2024
Home Tags Mavacamten

Tag: Mavacamten

Mavacamten Demonstrated Significant Reduction in Need for Septal Reduction Thera… –...

0
Mavacamten is a first-in-class, investigational cardiac myosin inhibitor being developed by Bristol Myers Squibb Study met all primary and secondary endpoints and patients receiving...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News